Charles Schwab Investment Management Inc. decreased its position in Haemonetics Co. (NYSE:HAE) by 23.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 322,216 shares of the medical instruments supplier’s stock after selling 99,693 shares during the period. Charles Schwab Investment Management […]
